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alaria Control in War Areas was formed in 1942 to
ensure that the areas around military bases in the
southern United States remained malaria-free. Initial facil-
ities were modest, a few rooms on the sixth floor of the
Volunteer Building on Peachtree Street in Atlanta. Hardly
anyone could have foreseen the future of this small organ-
ization. But Joseph W. Mountin, who was charged with
setting it up, was not just anyone. An architect of modern
public health, Mountin quickly realized that malaria con-
trol operations serving the needs of the states (response to
state calls for help, laboratory and epidemiologic investi-
gations, training) could become the foundation for improv-
ing the health of the nation.
Indeed, in 1946 the Public Health Service established
the Communicable Disease Center to work not only on
malaria but on typhus and other infectious diseases. The
following year, a token payment of $10 was made for a 15-
acre area on Clifton Road to house the operations. In the
next 60 years, minor changes were made to the name
(Center for Disease Control, Centers for Disease Control,
Centers for Disease Control and Prevention), but the ini-
tials, CDC, remained the same. The campus on Clifton
Road grew to include 2 biosafety level 4 laboratories and
other state-of-the-art facilities; operations were established
in Morgantown, Cincinnati, Fort Collins, and overseas;
and the work expanded to include all infectious diseases,
as well as occupational health, toxic chemicals, injury,
chronic diseases, health statistics, and birth defects.
A magnet for gifted scientists and other professionals
looking to serve in public health, CDC has attracted an
exceptional cadre of talent over the years. Mountin was
succeeded by leaders who pushed the agency to new levels
of achievement, constantly probing new challenges and
seeking new public health solutions. The thousands who
work in laboratories and offices or trot the globe on epi-
demiologic investigations; the physicians, veterinarians,
microbiologists, statisticians, economists, social scientists,
other scholars, and support personnel; the many volunteers
who serve on institutional review and other boards and
committees; and CDC’s many partners in academia, indus-
try, clinical practice, and state and local governments all
share unequivocal dedication to public health.
In this climate of idealism and dedication, the achieve-
ments have been many and span all areas. CDC scientists,
typically working with like-minded colleagues, identified
and characterized several infectious agents and emerging
infectious diseases; invented devices, tools, and stains for
diagnoses and systems for surveillance; demonstrated the
value of combining laboratory practices and epidemiolo-
gy; and through vision and leadership, worked closely with
state and local health departments to increase their effec-
tiveness as public health organizations. Some in its midst
made such major contributions that microorganisms were
named after them (Lee Ajello, Ajellomyces spp.; Dannie
Hollis, Vibrio hollisiae; Don Brenner, Neisseria brenneri;
Robert Weaver, Neisseria weaveri; Joseph McDade,
Legionella micdadei).
CDC led the US campaign to immunize all children
against vaccine-preventable infectious diseases; efforts to
“link” states in search of foodborne disease outbreak
causes by using molecular approaches to trace the
causative organisms (PulseNet); efforts to translate science
to practice, protecting women and children from such
emerging infection-related conditions as toxic shock syn-
drome and aspirin-associated Reye syndrome.
Achievements in international health have been major
benchmarks. CDC contributions range from support for
and leadership of the global effort to eradicate smallpox to
the establishment of Projet SIDA in Africa to initiate sci-
entific research on the HIV/AIDS epidemic.
Science has changed in the past 60 years. Laboratory
techniques used to detect, identify, and characterize
microorganisms have moved from Petri dish and viral cul-
ture to real-time polymerase chain reaction and genome
sequencing. During the 1976 Christmas holidays, a CDC
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USAlaboratory scientist, using simple microbiologic methods,
injected guinea pigs with material from persons who died
of Legionnaires’ disease. When some guinea pigs died, he
injected their spleen into chicken eggs. He saw what was
later confirmed to be the cause of this disease by looking
under the light microscope (Figure 1). Thirty years later,
others at CDC are able to identify all of almost 200,000
nucleotides that compose the genome of the smallpox virus.
But science moves on. Recently, CDC scientists and
colleagues have been able to recreate and reconstruct the
1918 influenza virus that caused the death of 40 to 50 mil-
lion people (Figure 2). Information technology advances
have enabled modeling to predict illness and death under
specific circumstances, facilitate advance planning, and
improve preparations for natural and human-made
disasters.
Infectious diseases have changed in the past 60 years.
All but hailed as being under control, they have found new
virulence, emerging and reemerging globally without end.
The new landscape of disease has required changes in
management and control. The spectrum of science expert-
ise has broadened, from entomologists and parasitologists
(at Malaria Control in War Areas and the 1950s) to epi-
demiologists, microbiologists, and immunologists (pre-
dominating in the 1960s to 1980s). Over the past 2
decades, the CDC community has become increasingly
multidisciplinary, embracing molecular biologists, geneti-
cists, bioinformatics specialists, statisticians/mathemati-
cians, behavioral and social scientists, modelers,
economists, and other scholars.
What have not changed are the unique links between
epidemiology and multiple other disciplines and between
science and practice that keep CDC on the “speed dial” of
every state and local public health official, every World
Health Organization representative, and every minister of
health worldwide. What has not changed is CDC’s passion
for science and public health. CDC scientists are proud to
have served with so many colleagues and partners around
the world on some of the greatest challenges to public
health over the past 60 years. Nothing tells us we can rest
on our collective laurels, impressive though they may be.
Indeed, the most important lesson we have learned is that
working together in research, applied public health, and
preventive action is paramount because the emerging
infectious disease and microbiologic challenges of the next
60 years may be even tougher than those we have already
faced.
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Figure 1. On January 14, 1977, the director of the Center for
Disease Control’s laboratory division, Charles C. Shepard (right),
and microbiologist Joseph E. McDade isolated the agent that
caused an outbreak of respiratory disease among members of the
American Legion in July 1976. (Photo courtesy of Public Health
Image Library, Centers for Disease Control and Prevention)
Figure 2. Terrence Tumpey recreated the 1918 influenza A (H1N1)
virus to identify characteristics that made it such a deadly patho-
gen. (Photo by James Gathany, courtesy of Public Health Image
Library, Centers for Disease Control and Prevention)